Walgreens ensures greater COVID-19 treatment access to Americans, directly to their doorsteps
Today, in partnership with DoorDash and Uber, Walgreens announced free delivery of Paxlovid, a COVID-19 oral antiviral therapy.
With more than 8,000 Walgreens locations offering same day delivery services, available to anyone who lives within 15 miles of participating Walgreens locations, the majority of Americans have access to this program, about 92% of the population.
This initiative is aimed at increasing access to COVID-19 treatment, with a focus on reaching those in socially vulnerable or medically underserved areas at a time when COVID-19 cases are beginning to rise again across the United States. According to Walgreens COVID-19 Index data, overall positivity rates reached 36 percent this week. This steady rise in cases reinforces the critical need for access to life-saving treatments.
“The COVID-19 pandemic has exacerbated health disparities and emphasized the need to address long-standing barriers, including access to treatments,” said Anita Patel, PharmD, vice president, pharmacy services development, Walgreens. “Our pharmacy teams will continue to play a trusted and essential role in helping to keep people protected from COVID-19, including getting people vaccinated, tested and treated as safely, equitably and effectively as possible.”
Eligible patients must have a Paxlovid prescription from a healthcare provider. After the pharmacy has filled the prescription and before it gets picked up, individuals can go online to select Same Day Delivery by visiting Walgreens.com/PrescriptionDelivery, the Walgreens app or by calling their store.
This initiative is the latest offering in an ongoing collaboration between Walgreens, DoorDash and Uber to increase accessibility of life-saving treatments to medically underserved and underrepresented areas, following the companies’ response to the White House COVID-19 call to action to ensure a safe and healthy winter.